TABLE 2.
Preoperative baseline recipients-related characteristics.
| Recipients-related characteristics | Overall population n = 400 | RAKT n = 200 | OKT n = 200 | p | |
|---|---|---|---|---|---|
| Age (yr) (median, IQR, Range) | 50.0 (38.0–60.0) (18.0–82.0) | 48.0 (36.3–58.0) (18.0–77.0) | 51.5 (41.0–61.0) (18.0–82.0) | 0.045 | |
| BMI (kg/m2) (median, IQR, Range) | 24.7 (21.9–27.8) (15.4–44.7) | 24.8 (21.9–28.4) (16.9–44.7) | 24.6 (21.9–27.7) (15.4–39.4) | 0.5 | |
| Male (n, %) | 239 (59.8%) | 122 (61.0%) | 117 (58.5%) | 0.7 | |
| Comorbidities (n, %) | High blood pressure | 335 (83.8%) | 167 (83.5%) | 168 (84.0%) | 0.9 |
| Diabetes mellitus | 74 (18.5%) | 17 (8.5%) | 57 (28.5%) | <0.0001 | |
| Dyslipidaemia | 125 (31.3%) | 49 (24.5%) | 76 (38.0%) | 0.004 | |
| Recipient nephropathy (n, %) | Autosomal dominant polycystic kidney disease | 62 (15.5%) | 34 (17.0%) | 28 (14.0%) | 0.3 |
| IGA-nephropathy | 44 (11.0%) | 21 (10.5%) | 23 (11.5%) | ||
| Hypertensive nephropathy | 22 (5.5%) | 5 (2.5%) | 17 (8.5%) | ||
| Diabetic nephropathy | 37 (9.3%) | 11 (5.5%) | 26 (13.0%) | ||
| Glomerulonephritis | 69 (17.3%) | 43 (21.5%) | 26 (13.0%) | ||
| Congenic uropathy | 24 (6.0%) | 9 (4.5%) | 15 (7.5%) | ||
| Alport syndrome | 5 (1.3%) | 4 (2.0%) | 1 (0.5%) | ||
| Lupus nephritis | 5 (1.3%) | 2 (1.0%) | 3 (1.5%) | ||
| Haemolytic uremic syndrome | 5 (1.3%) | 2 (1.0%) | 3 (1.5%) | ||
| Other/Unknown | 127 (31.8%) | 69 (34.5%) | 58 (29.0%) | ||
| Major previous abdominal surgery (n, %) | 202 (50.5%) | 87 (43.5%) | 115 (57.5%) | 0.01 | |
| Previous kidney transplantation (n, %) | 61 (15.3%) | 22 (11.0%) | 39 (19.5%) | 0.03 | |
| Preemptive recipient (n, %) | 242 (60.5%) | 125 (62.5%) | 117 (58.5%) | 0.5 | |
| Time on dialysis (months) (median, IQR, Range) | 8.0 (4.0–18.0) (1.0–228.0) | 6.0 (3.5–12.0) (1.0–36.0) | 12.0 (4.8–32.5) (1.0–228.0) | 0.003 | |
RAKT, Robotic-assisted kidney transplantation; OKT, Open kidney transplantation; BMI, Body Mass Index. Bold values indicate statistically significant results (p < 0.05).